All In Biotech

Drug Trial Radar · NCT06632977

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

474

Planned (sponsor's estimate)

Start

Feb 6, 2025

Primary completion

Apr 11, 2030

Study completion Oct 11, 2034

Sponsor

Lead sponsor
Alliance for Clinical Trials in OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Oct 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous surgery or biopsy procedure and tested for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) abnormalities or mutations in their cancer. Valemetostat tosylate is in a class of medications called EZH1/EZH2 inhibitors. It blocks proteins called EZH1 and EZH2, which may help slow or stop the spread of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Cabazitaxel injection is in a class of medications called microtubule inhibitors. It works by slowing or stopping the growth of tumor cells. Abiraterone acetate blocks tissues from making androgens (male hormones), such as testosterone. This may cause the death of tumor cells that need androgens to grow. It is a type of anti-androgen. Enzalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of tumor cells. Lutetium Lu 177 vipivotide tetraxetan is in a class of medications called radiopharmaceuticals. It works by targeting and delivering radiation directly to tumor cells which damages and kills these cells. Assigning patients to targeted treatment based on genetic testing may help shrink or slow the cancer from growing

Conditions

  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8

Interventions

  • Genetic testingOther

    undergo genetic testing

  • Valemetostat TosylateDrug

    Given PO

  • Magnetic Resonance ImagingProcedure

    undergo Magnetic Resonance Imaging

  • Computed TomographyProcedure

    undergo Computed Tomography

  • Bone scanProcedure

    undergo Bone scan

  • FDG-Positron Emission TomographyProcedure

    Undergo FDG PET

  • PSMA PET ScanProcedure

    Undergo PSMA PET

  • Biospecimen CollectionProcedure

    undergo blood collection

  • CarboplatinDrug

    Given IV

  • CabazitaxelDrug

    Given IV

  • Abiraterone AcetateDrug

    Given PO

  • EnzalutamideDrug

    Given PO

  • Lutetium Lu 177 Vipivotide TetraxetanDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective ResponseTime frame: Within 6 months from the start of treatment

Locations

108 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Recruiting

  • Banner University Medical Center - Tucson

    Tucson, Arizona · Recruiting

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona · Recruiting

  • Enloe Medical Center

    Chico, California · Recruiting

  • UC San Diego Health System - Encinitas

    Encinitas, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Active not recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Active not recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • UCHealth Memorial Hospital Central

    Colorado Springs, Colorado · Recruiting

  • Memorial Hospital North

    Colorado Springs, Colorado · Recruiting

  • Poudre Valley Hospital

    Fort Collins, Colorado · Recruiting

  • Cancer Care and Hematology-Fort Collins

    Fort Collins, Colorado · Recruiting

  • UCHealth Greeley Hospital

    Greeley, Colorado · Recruiting

  • Medical Center of the Rockies

    Loveland, Colorado · Recruiting

  • Stamford Hospital/Bennett Cancer Center

    Stamford, Connecticut · Recruiting

  • Beebe South Coastal Health Campus

    Millville, Delaware · Recruiting

  • Helen F Graham Cancer Center

    Newark, Delaware · Recruiting

  • Medical Oncology Hematology Consultants PA

    Newark, Delaware · Recruiting

  • Beebe Health Campus

    Rehoboth Beach, Delaware · Recruiting

  • Jupiter Medical Center

    Jupiter, Florida · Recruiting

  • Tripler Army Medical Center

    Honolulu, Hawaii · Recruiting

  • Kootenai Health - Coeur d'Alene

    Coeur d'Alene, Idaho · Suspended

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Canton

    Canton, Illinois · Recruiting

  • Carle at The Riverfront

    Danville, Illinois · Recruiting

  • Carle Physician Group-Effingham

    Effingham, Illinois · Recruiting

  • Illinois CancerCare-Eureka

    Eureka, Illinois · Recruiting

  • Carle Physician Group-Mattoon/Charleston

    Mattoon, Illinois · Recruiting

  • Cancer Care Center of O'Fallon

    O'Fallon, Illinois · Recruiting

  • Illinois CancerCare-Ottawa Clinic

    Ottawa, Illinois · Recruiting

  • Illinois CancerCare-Pekin

    Pekin, Illinois · Recruiting

  • Illinois CancerCare-Peoria

    Peoria, Illinois · Recruiting

  • Illinois CancerCare-Peru

    Peru, Illinois · Recruiting

  • Memorial Hospital East

    Shiloh, Illinois · Recruiting

  • Carle Cancer Center

    Urbana, Illinois · Recruiting

  • Illinois CancerCare - Washington

    Washington, Illinois · Recruiting

  • McFarland Clinic - Ames

    Ames, Iowa · Recruiting

  • University of Iowa Healthcare Cancer Services Quad Cities

    Bettendorf, Iowa · Recruiting

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.